Skip to main content
Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
2.360
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EST

Silence Therapeutics Revenue

In the year 2025, Silence Therapeutics had annual revenue of $559.00K, down -98.71%. Silence Therapeutics had revenue of $34.00K in the quarter ending December 31, 2025, a decrease of -99.87%.

Revenue
559.00K
Revenue Growth
-98.71%
P/S Ratio
650.63
Revenue / Employee
6.35K
Employees
88
Market Cap
363.70M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025559.00K-42.70M-98.71%
Dec 31, 202443.26M11.62M36.71%
Dec 31, 202331.64M9.99M46.12%
Dec 31, 202221.66M4.84M28.82%
Dec 31, 202116.81M9.33M124.73%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Northwest Biotherapeutics 1.38M
Vaxart 237.26M
BioStem Technologies 47.48M
Nuo Therapeutics 3.31M
Harvard Apparatus Regenerative Technology 704.00K
Revenue Rankings

Silence Therapeutics News

More News